🇺🇸

Earnings Results

· daily

US Earnings Financial Results SEC Filings — April 30, 2026

Across 50 Q1 2026 10-Q filings, revenues showed resilience with 32/50 companies reporting YoY growth averaging +12% (outliers like Glaukos +41.2%, Amazon +16.6%), though margins compressed in 28/50 (avg -150bps) due to rising opEx, labor, and R&D. Net income was mixed: 24 firms swung to or improved profitability (e.g., Amazon +76.7%, PBF turnaround from loss), but 26 posted widening losses, especially biotechs (Viking -3x, Cartesian -121%). Capital allocation emphasized returns with 22/50 executing buybacks (total ~$5B+, e.g., Chipotle $755M, KLA $1.72B 9M) and 18 raising/increasing dividends (e.g., NorthWestern +2%, InterDigital +17%). Cash flows improved operationally in 30/50 (avg +25% YoY), but high capex ($10B+ aggregate) and debt rises flagged balance sheet strains. Sector themes highlight tech strength (Alphabet +21.8% rev), auto recovery (Ford +6.4%), biotech cash burn, and energy volatility; actionable now: favor revenue growers with buybacks amid mixed sentiment (44/50 mixed). Portfolio implication: overweight tech/large caps with strong FCF, monitor biotechs for catalysts.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — April 29, 2026

Across 50 Q1 2026 10-Q filings, companies reported mixed results with aggregate revenue growth averaging ~15% YoY (e.g., Omnicom +69%, Bloom Energy +130%, Visa +17%), driven by sectors like advertising, energy, payments, and midstream, but offset by widespread margin compression (e.g., Sysco operating income -9.1%, GE HealthCare -18%) due to rising operating expenses (+10% avg in many), restructuring, and impairments. Capital allocation emphasized shareholder returns with buybacks (e.g., Visa $11.7B, Omnicom $2.8B annualized pace) and dividends (e.g., Welltower +10% YoY), alongside aggressive M&A (e.g., Veralto $426M, Parsons $334M, GE HealthCare $2.3B). Cash balances declined QoQ in 70% of filers (avg -20%), signaling working capital strains and investment outflows, while total assets grew in 60% via acquisitions/goodwill. Sentiment was mixed in 98% (negative in MGP Ingredients due to $180M impairment), highlighting cost pressures amid growth. Portfolio-level trends point to resilient top-line but profitability risks; utilities/finance showed stability, pharma/energy outliers in growth. No major guidance changes noted, but M&A integration and Q2 earnings calls loom as catalysts. Implications: Favor high-conviction buyback names; trim margin squeezes.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — April 28, 2026

Across 50 Q1 2026 US SEC filings, primarily 10-Qs, overarching themes include robust revenue growth averaging ~8-10% YoY in 18/23 detailed filers (e.g., Herc +32%, Centene +7%, Valmont +6%) offset by widespread margin pressures from rising expenses (e.g., Herc op ex +38%, JetBlue +6.5%), resulting in mixed profitability and predominantly 'mixed' sentiment (20/23 detailed). Cash flow trends are bifurcated with operating cash improving in 10 cases (e.g., Centene +189% YoY to $4.4B, Hilton +37%) but deteriorating in others (e.g., Shutterstock -31%, Hillman to negative). Capital allocation favors shareholder returns via buybacks (e.g., Valmont $58M, Xylem $563M) and dividends (e.g., Pool raised to $1.25/share), amid QoQ cash declines in 15/23. Financials and industrials show relative outperformance with EPS growth (Bread +50%, Franklin +77%), while microcaps like Jubilant and reAlpha highlight liquidity risks. Portfolio-level implications point to selective buying in high-conviction growth names, caution on expense-heavy sectors, and monitoring capex/reinvestment amid moderating asset growth.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — April 27, 2026

Across 28 filings in the Financial Results & Earnings stream, overarching themes include mixed sentiment with robust revenue growth in industrials (e.g., Steel Dynamics +19% YoY, Celestica +52.8%), insurance (Cincinnati swing to profit), and M&A-driven tech (Sanmina sales doubled), contrasted by sharp declines in microcaps/development (International Land -70% YoY revenue) and retail (Albertsons operating income -53%). Period-over-period trends show 14/28 companies with YoY revenue growth averaging +20% for outperformers, but aggregate profitability mixed due to margin pressures (e.g., Domino's net income -6.6%) and one-time gains; cash flows deteriorated in 12 firms (avg -20% YoY operating cash). Capital allocation emphasizes shareholder returns with buybacks in 10 companies (e.g., Domino's +50% YoY to $75M) and dividends steady/up in most (e.g., Steel Dynamics +6%). Acquisitions boosted assets in 6 filings (e.g., SEI goodwill +9.4% QoQ, Alternus +644%), signaling growth conviction amid sector rotation. Portfolio-level patterns flag real estate resilience via sales gains (Brixmor net income +83%) but debt rises; market implications point to tactical longs in cyclicals/metals, caution in consumer/discretionary.

28 high priority 28 total filings
· daily

US Earnings Financial Results SEC Filings — April 24, 2026

Across 47 Q1 2026 earnings filings (primarily 10-Qs), mixed sentiment prevails with 45/47 rated mixed or negative, reflecting revenue growth averaging +8% YoY in large-caps (e.g., Intel +7%, LVS +25%, TI +19%) offset by profitability pressures from restructuring (Intel $4B charges), cost inflation (SkyWest fuel +59%), and impairments (Meritage $2.4M). Margin compression hits 18/47 companies (avg -100bps), particularly telecom (Charter video -9%) and homebuilders (Meritage -35% gross profit), while semiconductors (TI +19% rev, +31% NI) and energy services (Halliburton +129% NI) outperform. Capital allocation remains shareholder-friendly with buybacks/dividends in 35+ firms (e.g., Nasdaq $548M buybacks, LVS $746M), signaling management conviction amid 12/47 showing cash burn. Cash flow trends mixed: 22 improved YoY (e.g., Dow +$1B), 20 declined (e.g., Western Union -26%). Portfolio-level: Rotate from cyclicals (chemicals Dow -6% rev) to defensives (P&G +7% sales). Sector rotation opportunities in semis/energy; watch debt spikes (PMI short-term borrow +$5.5B). Actionable: Buyback-heavy names offer downside protection in volatile macro.

47 high priority 47 total filings
· daily

US Earnings Financial Results SEC Filings — April 23, 2026

Across 50 US SEC filings for Q1/FY2026 financial results, sentiment is predominantly mixed (44/50), with revenue growth averaging +12% YoY in outperformers like tech (ServiceNow +22%, Lam Research +23.8%) and industrials (Comfort Systems +56.4%, Kaiser Aluminum +42%) offsetting declines in consumer goods (Helen of Troy -6.4%) and homebuilding (Century Communities -12.6%, PulteGroup -12.4%). Margin compression is evident in 18/50 companies (e.g., Waste Connections operating income -6.7% amid impairments), while net income swings highlight volatility (e.g., Southwest Airlines profit swing from -$149M to +$227M). Capital allocation leans heavily toward shareholder returns, with 32/50 reporting buybacks/dividends (e.g., ServiceNow $2.225B repurchases, Lam Research $3.6B treasury purchases), signaling management conviction despite cash declines in 28/50. Utilities and financials show resilience (PG&E +15% revenues, Texas Capital +56.8% net income), but impairments total >$5B (Helen $886M, Mobileye $3.8B). Portfolio-level trend: Organic growth weak in cyclicals, but M&A/acquisitions in 12 firms boost topline. Implications: Favor growth sectors over consumer/homebuilders; watch capex spikes in energy/defense for inflation risks.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — April 22, 2026

Across 36 Q1 2026 financial filings (mostly 10-Qs, some 10-Ks), revenue growth averaged ~10-15% YoY in high performers like GE Vernova (+16%), Vertiv (+30%), EQT (+94%), and Intuitive Surgical (+23%), but was mixed with declines in homebuilding (Taylor Morrison -27%), beverages (Constellation -10%), and healthcare services (Community Health -6%). Profitability showed stark contrasts: blowout net income surges (GE Vernova to $4.7B, EQT +515%) versus widening losses (Reborn Coffee -87%, KKR RE to $57M loss). Capital allocation leaned heavily toward aggressive buybacks totaling billions (e.g., Calix $172M, J&J $4B, Intuitive $1.1B) and acquisitions (GEV $4.9B, Boeing Spirit $8.4B, Wabtec $1.1B), signaling management conviction amid cash generation improvements in 20+ firms (e.g., United Airlines +29% op cash). Margin trends were pressured in 12/36 companies (avg -50-200bps compression from costs/investments), but industrials/energy outperformed with expansion. REITs faced credit/impairment hits (KKR +196% provisions), while airlines/industrials showed resilience. Portfolio implication: overweight growth industrials/energy on buybacks/M&A; trim cyclical decliners like housing/REITs ahead of potential slowdowns.

36 high priority 36 total filings
· daily

US Earnings Financial Results SEC Filings — April 21, 2026

Across 21 Q1 2026 filings, revenue growth was a dominant theme with 16/21 companies reporting YoY increases averaging +16% (led by GE Aerospace +24.7%, Range Resources +50%, Aircastle +18.8%), though profitability was mixed: 12/21 saw net income growth (avg +35% where positive) but 6 experienced declines (avg -45%), driven by higher expenses and one-offs. Margin compression appeared in 8/21 (e.g., GE Aerospace 26.4% vs 28.7%, 3M EPS -40%), offset by operational leverage in defense (Northrop op income +73%) and leasing (Aircastle EBITDA +19.7%). Capital allocation leaned shareholder-friendly with buybacks in 7/21 (total ~$1.5B, e.g., MSCI $414.8M, Pegasystems $167M) and dividend hikes in 5 (e.g., Northrop $2.31 vs $2.06, Range $0.10 vs $0.09), but cash burns persisted in 9/21 amid acquisitions/investments. Sector strength in aerospace/defense (GE, Northrop, RTX, Aircastle) and water/industrials (Zurn +11.4% sales), contrasted by weakness in small-caps (Fly-E -53% rev, Pacific negative sentiment). Implications: Bullish for large-cap industrials/defense on growth/margins; caution on micro-caps with cash depletion; portfolio rotation toward buyback-heavy names like MSCI/Equifax for near-term returns.

21 high priority 21 total filings
· daily

US Earnings Financial Results SEC Filings — April 20, 2026

Across these 10 US SEC filings for Q1/9M/YE 2026 financial results, a dominant theme is explosive revenue growth in hyper-scaling small caps (e.g., Karbon-X +3,869% YoY, Laser Photonics +144% YoY) clashing with widening net losses and deepening equity deficits, signaling aggressive expansion at the cost of profitability. Period-over-period trends reveal mixed revenue performance: 5/10 companies posted YoY growth (avg +728% skewed by outliers), but 6/10 reported operating/net losses expanding YoY (avg loss magnification 200%+), with gross margins stable or improving in 4 cases (e.g., MIND Tech +100 bps to 46%). Balance sheets deteriorated in 7/10 (liabilities up avg 150%, cash depletion in 5), offset by financing inflows in growth names. Capital allocation leans toward debt/equity issuance for funding (e.g., Karbon-X $10.3M financing), with rare shareholder returns (Badger Meter dividend +18%, $38.2M buybacks). REIT NETSTREIT stands out with 24% revenue growth and acquisitions ($234M), while zero-revenue shells like Blue Chip and UbuyHoldings flash high distress. Portfolio implication: Favor selective growth bets on improving cash flows (AlphaVest +1,852% cash) amid broad small-cap risk of dilution/insolvency.

10 high priority 10 total filings
· daily

US Earnings Financial Results SEC Filings — April 17, 2026

Across 11 filings, financial results reveal stark divergence: robust growth in tech/media (Netflix +16% revenue, FDCTech +30%) contrasts with declines in consumer, real estate, and SPACs (Hooker -12%, Sunrise -15%, Farmhouse -85%). Period-over-period trends show 5/11 companies with revenue growth averaging +25% YoY (Netflix, FDCTech, MiniMed, Dream Homes, Autoliv), but 6/11 reported widening losses or net asset declines (e.g., EQUUS NAV -45%, Sunrise impairment $21.8M). Margin resilience in select names (FDCTech gross +1010bps to 54.8%, Hooker +180bps) offsets compressions elsewhere (MiniMed gross -8%). Capital allocation mixed with Netflix buybacks at $1.27B (down YoY) and Dream Homes distributions $1.97M eroding equity -41%. SPACs like Tech&Telecom and Renewable show deepening deficits amid zero revenue. Implications: Bullish for high-growth outliers like Netflix; caution on cyclical/declining sectors with portfolio-level loss trends signaling selective rotation opportunities.

11 high priority 11 total filings
· daily

US Earnings Financial Results SEC Filings — April 16, 2026

Across 32 filings primarily covering FY2025 10-Ks and Q1 2026 10-Qs, sentiment is overwhelmingly mixed (25/32), with microcap/development-stage firms (e.g., SEATech, JOCOM, Catalyst Crew) showing narrowed losses via expense cuts (avg ~70% improvement in 8 cases) but persistent zero revenue and going concern risks, while larger caps like PepsiCo (+8.6% revenue YoY), Fastenal (+12.4%), and Travelers (+333% net income) drove positive trends. Portfolio-level, revenue grew in 12/32 (avg +20% YoY where positive), but declined in 14 (avg -40%), with gross margins compressing in 10/32 (avg -200bps, e.g., Lakeland -820bps). Acquisitions/share issuances boosted assets in 15 firms (avg +100% YoY), but cash burn persists in 20+, offset by financing. Capital allocation leans toward buybacks/dividends in stables (Travelers $1.8B buyback, Fastenal dividend +12%), signaling conviction, while microcaps dilute via issuances. Key implication: Opportunities in turnaround microcaps narrowing losses and established consumer/insurance names, but watch margin pressures and working capital deficits amid 2026 economic uncertainty.

32 high priority 32 total filings
· daily

US Earnings Financial Results SEC Filings — April 15, 2026

Across 50 US SEC 10-K filings for FY2025 (period ending ~Dec 31, 2025), small-cap and micro-cap companies dominate with mixed sentiment (28/50 mixed, 10 negative), reflecting persistent operating losses amid revenue volatility: 22 companies saw revenue declines (avg -35% YoY, e.g., Polar Power -55%, Cenntro -42%), while 12 posted growth (avg +85% YoY, outliers Gloo Holdings +308%, Vivakor segment +87%). Net losses widened in 60% of filers (avg +50% YoY magnitude), driven by R&D/SG&A spikes and impairments, though 8 achieved profitability swings via one-offs (e.g., Oncotelic +$249M from investment fair value). Balance sheets improved via $1B+ aggregate financing (equity/debt), boosting cash/assets in 65% but deepening dilutions/shareholder deficits elsewhere; cash burn worsened in 70% (avg +40% YoY operating use). SPACs (e.g., Horizon Space, Constellation) faced heavy redemptions (avg 90% trust erosion), signaling de-SPAC fatigue. Biotech/pharma (12/50) showed R&D escalation (+100% avg) with commercialization catalysts, while energy/mining had modest production gains. Implications: Favor turnaround outliers with revenue ramps and monitor liquidity risks; portfolio tilt to revenue growers like Citi Trends amid broad weakness.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — April 14, 2026

Across 45 SEC filings in the Financial Results & Earnings stream (mostly 10-Q/10-K from small-cap US companies), overarching themes include widespread revenue declines (17/45 companies reported YoY drops averaging -40%, e.g., SemiLEDs -90%, Greystone -76%) and net loss expansions (25/45 widened losses YoY, avg +50%), offset by financing-driven cash boosts in 30+ cases and explosive growth outliers like BITMINE (+390% rev) and ABQQ (+236%). Mixed sentiment prevails (32/45), with SPACs (8 filings) stable via trust income (e.g., Legato IV +$686k net income from investments), while impairments (Saga $20M goodwill, Heritage $118M intangibles) and related-party reliance signal distress. Period trends show QoQ cash improvements in 20 companies (avg +50%) but margin compression (-150bps avg in 12 reporters) and dilution via share issuances (e.g., BITMINE shares doubled). No broad insider trading patterns, but capital allocation leans conservative (dividends cut in Saga -37.5%, Immersion declared $1.5M). Market implications: High volatility in microcaps, alpha in growth outliers amid sector rotation from cyclicals; portfolio caution on trade policy risks (Northann) and going concerns (Greystone, Go Go Buyers).

45 high priority 45 total filings
· daily

US Earnings Financial Results SEC Filings — April 13, 2026

Across 23 filings, sentiment is predominantly mixed (17/23), reflecting resilient revenue growth in select manufacturers and distributors (e.g., Arts-Way +29% YoY sales, EACO +17.7%) offset by widespread declines in tech, biotech, and consumer sectors (avg revenue drop ~15% YoY in 10 companies including Kopin -21.9%, Biomerica -21.6% 9M). Margin compression is a portfolio-level trend, affecting 9/23 companies with average -150 bps YoY (e.g., Digital Ally to 10% from 23%, Wetouch 31.8% from 32.2%), driven by cost pressures and crypto losses (Pineapple -$23M FV loss). Balance sheets show bifurcation: 8 companies strengthened via financing/dilution (e.g., Pineapple assets x9 to $48.9M, CONX equity positive $55M), while 7 saw cash/inventory deterioration amid operating losses. Net losses narrowed in 10 firms (avg improvement ~30% YoY), but dilution is rampant (12/23 with shares up >10x in cases like Edgemode 7,679% increase). No dominant insider patterns noted, but customer concentration (Wetouch top customers, Elite 100% FedEx) and China risks (Wetouch, others) emerge as systemic vulnerabilities. Q4/Q1 improvements signal potential inflection (New Fortress Q4 rev +19% QoQ), positioning nimble operators for recovery amid economic volatility.

23 high priority 23 total filings
· daily

US Earnings Financial Results SEC Filings — April 10, 2026

Across 22 filings in the Financial Results & Earnings stream, sentiment is predominantly mixed (15/22), with negative tones in retail (Childrens Place -12.8% sales YoY, FGI -1% rev), media (Cumulus -10.3% rev), and digital assets (GD Culture -96.3% cash QoQ), offset by growth outliers like Simulations Plus (+8.3% Q rev YoY, +47.5% NI) and ASP Isotopes (+475% rev). Period-over-period trends show revenue declines averaging -10% YoY in 12/22 companies, but net losses narrowing in 14/22 via cost cuts (e.g., EvoAir op ex -65%, Brownie's working capital +240%), alongside persistent cash burn (16/22 declining cash positions) and equity dilutions (e.g., Balance Labs shares +100%). Capital allocation leans toward financing inflows and equity issuances over dividends/buybacks, with no splits noted; operational metrics highlight R&D surges in biotech/pharma (Quince +90%, Scilex +115%, Stimcell +7316% Q). Portfolio-level implications include sector rotation from consumer/retail to niche tech/services, with alpha in loss-narrowing turnarounds amid high materiality (avg 8/10). No explicit forward-looking guidance or insider trades reported, but trial successes (Scilex SP-102 Phase 3 met endpoints) signal catalysts; watch for cash sustainability in microcaps.

22 high priority 22 total filings
· daily

US Earnings Financial Results SEC Filings — April 09, 2026

Across 24 filings in the Financial Results & Earnings stream, overarching themes reveal a bifurcated market with 14/24 companies reporting YoY revenue declines averaging -12.5% (e.g., Beyond Meat -15.6%, KB Home -22.6%, Lennar -13.3%), driven by housing weakness and consumer pullback, while 10 showed growth averaging +18% (e.g., Healthy Extracts +45%, WD-40 +10.7%, Worthington Enterprises +24.4%). Margin compression affected 9/24 firms (avg -250 bps, e.g., Simply Good Foods impairment), but loss narrowing was common in 12 cases (e.g., Resources Connection net loss -78% YoY, BlackBerry swing to profit). Capital allocation leaned defensive with buybacks/dividends in homebuilders (KB Home $50M repurchases, Lennar $270M), but cash burn rose in 8 microcaps. Homebuilding sector dragged portfolios (revenue -18% avg), contrasting resilient industrials (Worthington +20% sales). SPACs face redemption risks (IX Acquisition trust -52%). Implications: Trim housing exposure, seek turnaround alpha in mixed-sentiment small caps with improving losses.

24 high priority 24 total filings
· daily

US Earnings Financial Results SEC Filings — April 08, 2026

Across 26 filings in the Financial Results & Earnings stream, results are predominantly mixed (17/26), with revenue growth in 12 companies averaging +40% YoY (outliers: Applied Digital +139%, Pure Cycle +47%) offset by sharp declines in 10 others (avg -40% YoY, e.g., Nurix -66%, Aehr -44%). Margin compression is widespread (8/26 companies, avg -150 bps), driven by rising opex/R&D, while net losses widened in 14 firms amid impairments (e.g., Beasley $225M FCC licenses) and cash burn (15/26 cash declines, avg -50%). Positive net income in 6 companies (e.g., Grown Rogue turnaround to $3.2M profit, Jabil +91% YoY) contrasts small-cap struggles, with biotech/pharma and media hit hardest. Capital allocation favors buybacks/dividends in performers (e.g., Pure Cycle repurchases, PriceSmart dividends up), but equity issuances dilute in cash-strapped firms (17/26). Portfolio implication: Rotate into revenue growers like Jabil/Applied Digital; avoid cash-deficient microcaps. Forward risks from low cash (SmartKem $374k) and SPAC deadlines signal near-term catalysts.

26 high priority 26 total filings
· daily

US Earnings Financial Results SEC Filings — April 07, 2026

Across 17 filings, results reveal a bifurcated market with resilient services and financial firms (e.g., Cintas +8.9% YoY revenue, Jefferies +16.1%) offsetting declines in manufacturing/tech (Greenbrier -23% YoY, Cambium -21.8%) and biotechs (Jaguar Health losses widening 37.6% YoY), yielding aggregate revenue growth near flat but with margin volatility (improvements in Cambium +160 bps gross margin, compressions in UniFirst op income -16.7%). Capital allocation leans shareholder-friendly via buybacks (Cintas $933M YTD, UniFirst $33M H1) and dividends (Greenbrier $0.64/share, Phoenix $0.21/share), though cash burn persists in early-stage firms (Cell Source going concern doubt, Thunder Power cash to $10K). SPACs show IPO strength (APEX trust $112M), while education peers struggle (Skillsoft flat revenue, Phoenix net income -58%). Forward-looking catalysts cluster in biotech milestones (Cell Source Phase 2 by 2028), with no major guidance changes but elevated risks from impairments (Cambium $25.5M, Skillsoft 6.2% of rev). Portfolio implication: Favor services/consumer outperformers amid cyclical weakness, monitor cash flows for 9 mixed-sentiment names.

17 high priority 17 total filings
· daily

US Earnings Financial Results SEC Filings — April 06, 2026

Across the 8 filings in the Financial Results & Earnings stream, small-cap and micro-cap companies predominantly reported mixed results with revenue growth in standout cases like SolarMax Technology (+296% YoY to $90.982M) and iQSTEL (+11.9% YoY to $316.9M), but widespread margin compression (e.g., SolarMax gross margin -550 bps to 4.6%, iQSTEL Q4 gross margin +72 bps but overall flat), net losses, and cash burn (e.g., STRATEGIC ACQUISITIONS -98% cash to $508, Nutra -90.1% to $3,603). Period-over-period trends show 4/8 companies with YoY revenue growth averaging +82% in winners, but 5/8 with widening or persistent net losses and deteriorating equity positions (e.g., Elvictor swung to -$175k loss, Neolara full asset impairment). Capital allocation leaned toward equity issuances and dividends (iQSTEL stock dividend $500k), with limited buybacks; no major M&A but forward-looking catalysts like Elvictor's nine Q1 2026 crew contracts signal potential turnarounds. Portfolio-level patterns indicate sector-agnostic cash constraints and operational volatility in finance/telecom/solar, implying high-beta opportunities amid Nasdaq compliance risks (SolarMax). Overall materiality skews high (avg 7.4/10), favoring selective longs on growth outliers while shorting cash burners.

8 high priority 8 total filings
· daily

US Earnings Financial Results SEC Filings — April 03, 2026

Across 12 US SEC filings in the Financial Results & Earnings stream, results reveal a bifurcated landscape with robust revenue growth in defense (Karman +36.6% YoY) and professional services (RCM +14.7% YoY, Concentrix +5.4% YoY, Ooma +7% YoY) offsetting sharp declines in lending/BDCs (TCW Direct -44% YoY, TCW VII -35.1% YoY), microcaps (Totaligent -99.5% YoY, Token -85% YoY), and others (POWERDYNE -7.2% YoY). Margin trends are mixed, with compression in 7/12 companies (e.g., Karman -2.9 pts, Concentrix operating -30% YoY) but improvements in adjusted EBITDA for Karman (+37%), Ooma (+46%), and RCM (+19%). Net losses narrowed in loss-making firms like GOOD GAMING (-75.5%), but cash burn persists in 8/12, with liabilities rising in 6/12 amid dilution and debt increases. Capital allocation shows shareholder focus via buybacks (RCM 114k shares, Concentrix 1k shares) and dividends (Concentrix $23M), signaling conviction in outperformers. Portfolio-level pattern: small-cap deterioration (8/12 revenue down avg -50% YoY) vs mid-cap resilience, implying rotation opportunities from distressed names to growth segments like defense/services. No insider activity or explicit guidance noted, but improving debt ratios (Karman 1.52 from 2.25) and backlog growth flag early recovery signals.

12 high priority 12 total filings